LSDIF (Lucy Scientific Discovery) Sloan Ratio %: 0.00% (As of Dec. 2023)


What is Lucy Scientific Discovery Sloan Ratio %?

Lucy Scientific Discovery LSDIF Sloan Ratio % is 0.00% as of Dec. 2023.

Richard Sloan from the University of Michigan was first to document what is referred to as the "accrual anomaly". His 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones.

Lucy Scientific Discovery's Sloan Ratio for the quarter that ended in Dec. 2023 was 0.00%.

As of Dec. 2023, Lucy Scientific Discovery has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Lucy Scientific Discovery  (OTCPK:LSDIF) Sloan Ratio % Explanation

A former University of Michigan researcher, Richard Sloan's 1996 paper found that shares of companies with small or negative accruals vastly outperform (+10%) those of companies with large ones. In fact, for the 40-year period between 1962 and 2001, buying the lowest accrual companies and shorting the highest accrual companies resulted in an average annual compounded return of 18%, more than double the S&P 500's 7.4% annual return over the same period.

According to How to Beat the Market with the Sloan Ratio:

If the Sloan Ratio is between -10% and 10%, the company is in the safe zone and there is no funny business with accruals.

If the Sloan Ratio is less than between -25% and -10% on the negative side, and between 10% and 25% on the positive side, this is a warning stage of accrual build up.

If the Sloan Ratio is less than -25% or greater than 25%, and this ratio is consistent over several quarters or even years, be careful. Earnings are highly likely to be made up of accruals.

As of Dec. 2023, Lucy Scientific Discovery has a Sloan Ratio of 0.00%, indicating the company is in the safe zone and there is no funny business with accruals.


Lucy Scientific Discovery Sloan Ratio % Related Terms


Lucy Scientific Discovery Sloan Ratio % Historical Data

* Premium members only.

The historical data trend for Lucy Scientific Discovery's Sloan Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lucy Scientific Discovery Sloan Ratio % Chart

Lucy Scientific Discovery Annual Data
Trend Jun21 Jun22 Jun23
Sloan Ratio %
0.00 -73.49 -50.76

Lucy Scientific Discovery Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Sloan Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

LSDIF vs INQD, ZTS, VTRS: Sloan Ratio % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Lucy Scientific Discovery's Sloan Ratio %, along with its competitors' market caps and Sloan Ratio % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lucy Scientific Discovery Sloan Ratio % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lucy Scientific Discovery's Sloan Ratio % distribution charts can be found below:

* The bar in red indicates where Lucy Scientific Discovery's Sloan Ratio % falls into.



Lucy Scientific Discovery Sloan Ratio % Calculation

Earnings contain a lot of non cash earnings which is called accruals. The Sloan ratio is a way to identify firms with low non-cash or accrual-derived earnings relative to their cash flow.

Lucy Scientific Discovery's Sloan Ratio for the fiscal year that ended in Jun. 2023 is calculated as

Sloan Ratio=(Net Income (A: Jun. 2023 )-Cash Flow from Operations (A: Jun. 2023 )
-Cash Flow from Investing (A: Jun. 2023 ))/Total Assets (A: Jun. 2023 )
=(-8.988--4.266
--0.266)/8.779
=-50.76%

Lucy Scientific Discovery's Sloan Ratio for the quarter that ended in Dec. 2023 is calculated as

Sloan Ratio=(Net Income (TTM)-Cash Flow from Operations (TTM))
-Cash Flow from Investing (TTM))/Total Assets (Q: Dec. 2023 )
=(-11.301--5.924
--0.423)/4.287
=-115.56%

Lucy Scientific Discovery's Net Income for the trailing twelve months (TTM) ended in Dec. 2023 was -4.106 (Mar. 2023 ) + -2.577 (Jun. 2023 ) + -1.998 (Sep. 2023 ) + -2.62 (Dec. 2023 ) = $-11.30 Mil.
Lucy Scientific Discovery's Cash Flow from Operations for the trailing twelve months (TTM) ended in Dec. 2023 was -2.035 (Mar. 2023 ) + -1.861 (Jun. 2023 ) + -1.288 (Sep. 2023 ) + -0.74 (Dec. 2023 ) = $-5.92 Mil.
Lucy Scientific Discovery's Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 was -0.3 (Mar. 2023 ) + 0 (Jun. 2023 ) + -0.123 (Sep. 2023 ) + 0 (Dec. 2023 ) = $-0.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Sloan Ratio % →
What does a Sloan Ratio % of 0.00% mean?
Lucy Scientific Discovery (LSDIF) has a Sloan Ratio % of 0.00% as of Dec. 2023. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Lucy Scientific Discovery and its competitors.
Is Lucy Scientific Discovery's Sloan Ratio % too high?
Lucy Scientific Discovery's current Sloan Ratio % is 0.00%.
How does Lucy Scientific Discovery's Sloan Ratio % compare to INQD and ZTS?
Lucy Scientific Discovery's Sloan Ratio % of 0.00% can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Sloan Ratio % for a Drug Manufacturers company?
A good Sloan Ratio % depends on the Drug Manufacturers industry context. However, Sloan Ratio % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Sloan Ratio % mean?
A high Sloan Ratio % can signal that a stock is expensive relative to its fundamentals. Sloan ratio measures earnings quality based on the amount of accruals. View historical data on Lucy Scientific Discovery and its competitors. Lucy Scientific Discovery's current Sloan Ratio % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lucy Scientific Discovery stock overvalued right now?
Lucy Scientific Discovery (LSDIF) has a current Sloan Ratio % of 0.00%. The current Sloan Ratio % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Sloan Ratio % calculated?
Sloan Ratio % is calculated from a company's financial statements. For Lucy Scientific Discovery (LSDIF), the current Sloan Ratio % is 0.00% as of Dec. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Lucy Scientific Discovery Business Description

Address 301-1321 Blanshard Street, Victoria, BC, CAN, V8W 0B6
Lucy Scientific Discovery Inc is an early-stage psychotropics contract manufacturing company focused on becoming the contract research, development, and manufacturing organization for the emerging psychotropics-based medicines industry. Its drug products are designed to treat a range of mental health and cognitive conditions.